Stephen Sampson

Global Public Affairs4 communications in the past year

Lobbies for

API Labs

The submission of an application for a ministerial exemption under s. 56 of the Controlled Drugs and Substances Act.

Recent activity

Feb 11, 2026

Stephen Sampson contacted Scott Tannas, Todd Lewis and Manuela Tomic on behalf of API Labs

Feb 10, 2026

Stephen Sampson contacted Guy Gallant on behalf of API Labs

Jan 31, 2025

Stephen Sampson contacted Jennifer Saxe on behalf of API Labs

Feb 12, 2024

Stephen Sampson contacted Ritu Banerjee, Rodrigo Arancibia, Laurel Chester and Simran Arulraj on behalf of JN Nova Pharma

Dec 14, 2023

Stephen Sampson contacted Marie-France Lalonde and Mahdi Ellorhaoui on behalf of JN Nova Pharma

Oct 18, 2023

Stephen Sampson contacted Eric Costen and Kendal Weber on behalf of API Labs

Oct 17, 2023

Stephen Sampson contacted Ophelia John and Eshan Naik on behalf of API Labs

Jun 22, 2023

Stephen Sampson contacted Shaili Patel on behalf of API Labs

May 9, 2023

Stephen Sampson contacted Shaili Patel on behalf of API Labs

Mar 7, 2023

Stephen Sampson contacted Sandenga Yeba and Victor Kandasamy on behalf of Exactis Innovation

Mar 1, 2023

Stephen Sampson contacted Elliott Lockington and Justin Mohr on behalf of API Labs

Feb 28, 2023

Stephen Sampson contacted Shaili Patel on behalf of API Labs

Most-lobbied officials

Guy GallantChief of Staff1

Manuela TomicSenior Policy Advisor1

Scott TannasSenator1

Todd LewisSenator1